跳至主要内容
临床试验/NCT03364803
NCT03364803招募中不适用

Treatment Outcomes for Patients With Cushing's Syndrome: a Prospective Data Collection Study

Memorial Sloan Kettering Cancer Center7 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2017年11月28日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
300
试验地点
7
主要终点
Collection of data on Cushing's Syndrome participants before and over time after surgical, medication, and/or radiation therapy.

研究概览

简要总结

The purpose of this study is to follow participants with Cushing's syndrome during the course of their routine care and to form a data registry to study long term participant outcomes.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
14 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 14 or older
  • Active or treated overt Cushing's (due to pituitary, ectopic, or adrenal tumor), mild adrenal Cushing's syndrome (MACS), or a silent corticotroph tumor
  • The diagnosis of CS or MACS will be made by the PI, based on the below Endocrine Society guidelines, the patient's clinical presentation, and the PI's judgment.
  • Diagnostic criteria for ACTH-dependent Cushing's are according to the Endocrine Society and European Society of Endocrinology guidelines and include: Elevated 24-hour urinary free cortisol (UFC), normal or elevated plasma ACTH, elevated midnight salivary cortisol levels, or classic dexamethasone suppression testing for CD (morning cortisol > 5 ug/dL after 1 mg overnight of classic 2-day low dose test) and a pituitary lesion on MRI (in the case of pituitary Cushing's). If patient does not have any of these results, pathology of ACTH tumor may confirm presence of disease.
  • Diagnostic criterion for MACS is according to the European Society of Endocrinology guidelines: Classic dexamethasone suppression testing for CS (morning cortisol >1.8 µg/dL after 1 mg overnight) and the presence of an adrenal adenoma.
  • Silent corticotroph tumors will be defined by surgical pathology demonstrating positivity for ACTH, in the absence of clinical and biochemical features of Cushing's syndrome.
  • In lieu of MRI, surgical, or laboratory reports, physician's assessment note including mention of results will also be used as source for eligibility purposes.

排除标准

  • Patients with a diagnosis of iatrogenic Cushing's.

结局指标

主要结局

Collection of data on Cushing's Syndrome participants before and over time after surgical, medication, and/or radiation therapy.

时间窗: up to 10 years after treatment

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (7)

Loading locations...

相似试验

Collecting Information About Treatment Results for... | 临床试验